TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now?Zacks Investment Research • 09/26/25
Illumina advances personalized cancer care with new pharma development partnershipsPRNewsWire • 09/23/25
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicinePRNewsWire • 09/18/25
ILMN Stock to Gain From the Launch of Illumina Protein Prep AssayZacks Investment Research • 09/09/25
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and developmentPRNewsWire • 09/03/25
Illumina (ILMN) Reliance on International Sales: What Investors Need to KnowZacks Investment Research • 08/05/25
Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 07/31/25
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 07/30/25
Illumina enhances flagship assay to accelerate access to comprehensive tumor profilingPRNewsWire • 07/30/25
Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic HeadwindsSeeking Alpha • 07/12/25
Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025PRNewsWire • 07/10/25
Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive yearPRNewsWire • 07/10/25